Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 67

1.

Ribavirin for Hepatitis E Virus Infection After Organ Transplantation: A Large European Retrospective Multicenter Study.

Kamar N, Abravanel F, Behrendt P, Hofmann J, Pageaux GP, Barbet C, Moal V, Couzi L, Horvatits T, De Man RA, Cassuto E, Elsharkawy AM, Riezebos-Brilman A, Scemla A, Hillaire S, Donnelly MC, Radenne S, Sayegh J, Garrouste C, Dumortier J, Glowaki F, Matignon M, Coilly A, Figueres L, Mousson C, Minello A, Dharancy S, Rerolle JP, Lebray P, Etienne I, Perrin P, Choi M, Marion O, Izopet J; Hepatitis E Virus Ribavirin Study Group .

Clin Infect Dis. 2019 Dec 3. pii: ciz953. doi: 10.1093/cid/ciz953. [Epub ahead of print]

PMID:
31793638
2.

Glomerulonephritis With Isolated C3 Deposits as a Manifestation of Subtotal Factor I Deficiency.

Boudhabhay I, Frémeaux-Bacchi V, Roumenina LT, Moktefi A, Goujon JM, Matignon M, Caudwell V, Audard V, El Karoui K.

Kidney Int Rep. 2019 May 31;4(9):1354-1358. doi: 10.1016/j.ekir.2019.05.1156. eCollection 2019 Sep. No abstract available.

3.

Simultaneous cytomegalovirus glomerulitis and BK virus nephropathy leading to kidney allograft loss.

Moktefi A, Kofman T, Sakhi H, Matignon M, Grimbert P.

Pathology. 2019 Oct;51(6):641-644. doi: 10.1016/j.pathol.2019.05.007. Epub 2019 Aug 27. No abstract available.

PMID:
31470994
4.

Prognostic Factors in Anti-glomerular Basement Membrane Disease: A Multicenter Study of 119 Patients.

Marques C, Carvelli J, Biard L, Faguer S, Provôt F, Matignon M, Boffa JJ, Plaisier E, Hertig A, Touzot M, Moranne O, Belenfant X, Annane D, Quéméneur T, Cadranel J, Izzedine H, Bréchot N, Cacoub P, Piedrafita A, Jourde-Chiche N, Saadoun D.

Front Immunol. 2019 Jul 18;10:1665. doi: 10.3389/fimmu.2019.01665. eCollection 2019.

5.

Survival and specific outcome of sickle cell disease patients after renal transplantation.

Gérardin C, Moktefi A, Couchoud C, Duquesne A, Ouali N, Gataut P, Karras A, Anglicheau D, Lefaucheur C, Figueres L, Albano L, Lionet A, Novion M, Ziliotis MJ, Louis M, Del Bello A, Matignon M, Dahan K, Habibi A, Galacteros F, Bartolucci P, Grimbert P, Audard V.

Br J Haematol. 2019 Dec;187(5):676-680. doi: 10.1111/bjh.16113. Epub 2019 Jul 26.

PMID:
31348518
6.

Daratumumab in Sensitized Kidney Transplantation: Potentials and Limitations of Experimental and Clinical Use.

Kwun J, Matignon M, Manook M, Guendouz S, Audard V, Kheav D, Poullot E, Gautreau C, Ezekian B, Bodez D, Damy T, Faivre L, Menouch D, Yoon J, Park J, Belhadj K, Chen D, Bilewski AM, Yi JS, Collins B, Stegall M, Farris AB, Knechtle S, Grimbert P.

J Am Soc Nephrol. 2019 Jul;30(7):1206-1219. doi: 10.1681/ASN.2018121254. Epub 2019 Jun 21.

PMID:
31227636
7.

[Evaluation of single kidney graft outcome in patients initially programmed for a dual kidney graft transplantation].

Merzeau N, Champy C, Such M, Klapp J, Chahwan C, Vordos D, Hoznek A, Matignon M, Grimbert P, de la Taille A, Salomon L.

Prog Urol. 2019 May - Jun;29(6):340-346. doi: 10.1016/j.purol.2019.04.003. French.

PMID:
31151914
8.

Epidemiology, Risk Factors, and Outcomes of Opportunistic Infections after Kidney Allograft Transplantation in the Era of Modern Immunosuppression: A Monocentric Cohort Study.

Attias P, Melica G, Boutboul D, De Castro N, Audard V, Stehlé T, Gaube G, Fourati S, Botterel F, Fihman V, Audureau E, Grimbert P, Matignon M.

J Clin Med. 2019 Apr 30;8(5). pii: E594. doi: 10.3390/jcm8050594.

9.

Impact of hypertensive emergency and rare complement variants on the presentation and outcome of atypical hemolytic uremic syndrome.

El Karoui K, Boudhabhay I, Petitprez F, Vieira-Martins P, Fakhouri F, Zuber J, Aulagnon F, Matignon M, Rondeau E, Mesnard L, Halimi JM, Frémeaux-Bacchi V.

Haematologica. 2019 Dec;104(12):2501-2511. doi: 10.3324/haematol.2019.216903. Epub 2019 Mar 19.

10.

Early Acute Microvascular Kidney Transplant Rejection in the Absence of Anti-HLA Antibodies Is Associated with Preformed IgG Antibodies against Diverse Glomerular Endothelial Cell Antigens.

Delville M, Lamarthée B, Pagie S, See SB, Rabant M, Burger C, Gatault P, Giral M, Thaunat O, Arzouk N, Hertig A, Hazzan M, Matignon M, Mariat C, Caillard S, Kamar N, Sayegh J, Westeel PF, Garrouste C, Ladrière M, Vuiblet V, Rivalan J, Merville P, Bertrand D, Le Moine A, Van Huyen JPD, Cesbron A, Cagnard N, Alibeu O, Satchell SC, Legendre C, Zorn E, Taupin JL, Charreau B, Anglicheau D.

J Am Soc Nephrol. 2019 Apr;30(4):692-709. doi: 10.1681/ASN.2018080868. Epub 2019 Mar 8.

PMID:
30850439
11.

Low incidence of acute rejection within 6 months of kidney transplantation in HIV-infected recipients treated with raltegravir: the Agence Nationale de Recherche sur le Sida et les Hépatites Virales (ANRS) 153 TREVE trial.

Matignon M, Lelièvre JD, Lahiani A, Abbassi K, Desvaux D, Diallo A, Peraldi MN, Taburet AM, Saillard J, Delaugerre C, Costagliola D, Assoumou L, Grimbert P; ANRS 153 TREVE study group.

HIV Med. 2019 Mar;20(3):202-213. doi: 10.1111/hiv.12700. Epub 2019 Jan 27.

PMID:
30688008
12.

Belatacept in renal transplant recipient with mild immunologic risk factor: A pilot prospective study (BELACOR).

Leibler C, Matignon M, Moktefi A, Samson C, Zarour A, Malard S, Boutin E, Pilon C, Salomon L, Natella PA, Durrbach A, Robert T, Canoui-Poitrine F, Grimbert P.

Am J Transplant. 2019 Mar;19(3):894-906. doi: 10.1111/ajt.15229. Epub 2019 Jan 25.

PMID:
30582270
13.

Minimal change nephrotic syndrome in patients infected with human immunodeficiency virus: a retrospective study of 8 cases.

Arrestier R, Satie AP, Zhang SY, Plaisier E, Isnard-Bagnis C, Gatault P, Raimbourg Q, Buob D, Vocila F, Heng AE, Francois H, Moktefi A, Canaud G, Matignon M, Dejucq-Rainsford N, Brocheriou I, Sahali D, Audard V.

BMC Nephrol. 2018 Nov 20;19(1):331. doi: 10.1186/s12882-018-1132-x.

14.

Rituximab and Fibrillary Glomerulonephritis: Interest of B Cell Reconstitution Monitoring.

Leibler C, Moktefi A, Matignon M, Debiais-Delpech C, Oniszczuk J, Sahali D, Cohen JL, Grimbert P, Audard V.

J Clin Med. 2018 Nov 9;7(11). pii: E430. doi: 10.3390/jcm7110430.

15.

Optimal oncologic management and mTOR inhibitor introduction are safe and improve survival in kidney and liver allograft recipients with de novo carcinoma.

Rousseau B, Guillemin A, Duvoux C, Neuzillet C, Tlemsani C, Compagnon P, Azoulay D, Salloum C, Laurent A, de la Taille A, Salomon L, Cholley I, Haioun C, Dupuis J, Wolkenstein P, Matignon MB, Grimbert P, Tournigand C.

Int J Cancer. 2019 Feb 15;144(4):886-896. doi: 10.1002/ijc.31769. Epub 2018 Nov 20.

PMID:
30155929
16.

Deep characterization of the anti-drug antibodies developed in Fabry disease patients, a prospective analysis from the French multicenter cohort FFABRY.

Mauhin W, Lidove O, Amelin D, Lamari F, Caillaud C, Mingozzi F, Dzangué-Tchoupou G, Arouche-Delaperche L, Douillard C, Dussol B, Leguy-Seguin V, D'Halluin P, Noel E, Zenone T, Matignon M, Maillot F, Ly KH, Besson G, Willems M, Labombarda F, Masseau A, Lavigne C, Froissart R, Lacombe D, Ziza JM, Hachulla E, Benveniste O.

Orphanet J Rare Dis. 2018 Jul 31;13(1):127. doi: 10.1186/s13023-018-0877-4.

17.

Clinical characteristics, risk factors, and outcome of tuberculosis in kidney transplant recipients: A multicentric case-control study in a low-endemic area.

Gras J, De Castro N, Montlahuc C, Champion L, Scemla A, Matignon M, Lachâtre M, Raskine L, Grall N, Peraldi MN, Molina JM.

Transpl Infect Dis. 2018 Oct;20(5):e12943. doi: 10.1111/tid.12943. Epub 2018 Jun 28.

PMID:
29890021
18.

Comparison of individually tailored versus fixed-schedule rituximab regimen to maintain ANCA-associated vasculitis remission: results of a multicentre, randomised controlled, phase III trial (MAINRITSAN2).

Charles P, Terrier B, Perrodeau É, Cohen P, Faguer S, Huart A, Hamidou M, Agard C, Bonnotte B, Samson M, Karras A, Jourde-Chiche N, Lifermann F, Gobert P, Hanrotel-Saliou C, Godmer P, Martin-Silva N, Pugnet G, Matignon M, Aumaitre O, Viallard JF, Maurier F, Meaux-Ruault N, Rivière S, Sibilia J, Puéchal X, Ravaud P, Mouthon L, Guillevin L; French Vasculitis Study Group.

Ann Rheum Dis. 2018 Aug;77(8):1143-1149. doi: 10.1136/annrheumdis-2017-212878. Epub 2018 Apr 25. Erratum in: Ann Rheum Dis. 2019 Sep;78(9):e101.

PMID:
29695500
19.

Treatment plans and outcomes in elderly patients reaching advanced chronic kidney disease.

Moranne O, Fafin C, Roche S, Francois M, Allot V, Potier J, Babici D, Lobbedez T, Matignon M, Mariat C, Vigneau C, Couchoud C.

Nephrol Dial Transplant. 2018 Dec 1;33(12):2182-2191. doi: 10.1093/ndt/gfy046.

PMID:
29562353
20.

Anticardiolipin antibodies and 12-month graft function in kidney transplant recipients: a prognosis cohort survey.

Gauthier M, Canoui-Poitrine F, Guéry E, Desvaux D, Hue S, Canaud G, Stehle T, Lang P, Kofman T, Grimbert P, Matignon M.

Nephrol Dial Transplant. 2018 Apr 1;33(4):709-716. doi: 10.1093/ndt/gfx353.

PMID:
29346631
21.

Safety of renal transplantation in patients with bipolar or psychotic disorders: a retrospective study.

Kofman T, Pourcine F, Canoui-Poitrine F, Kamar N, Malvezzi P, François H, Boutin E, Audard V, Lang P, Martinez F, Legendre C, Matignon M, Grimbert P.

Transpl Int. 2018 Apr;31(4):377-385. doi: 10.1111/tri.13078. Epub 2017 Oct 12.

22.

Outcome of second kidney transplantation in patients with previous post-transplantation Kaposi's sarcoma: A French retrospective study.

Bohelay G, Arzouk N, Lévy P, Rabaté C, Le Cleach L, Barete S, Barrou B, Matignon MB, Euvrard S, Lebbé C, Francès C; Skin and Organ Transplantation Group of the French Society of Dermatology.

Clin Transplant. 2017 Nov;31(11). doi: 10.1111/ctr.13091. Epub 2017 Oct 10.

PMID:
28833536
23.

Serum Iron Protects from Renal Postischemic Injury.

Vaugier C, Amano MT, Chemouny JM, Dussiot M, Berrou C, Matignon M, Ben Mkaddem S, Wang PHM, Fricot A, Maciel TT, Grapton D, Mathieu JRR, Beaumont C, Peraldi MN, Peyssonnaux C, Mesnard L, Daugas E, Vrtovsnik F, Monteiro RC, Hermine O, Ginzburg YZ, Benhamou M, Camara NOS, Flamant M, Moura IC.

J Am Soc Nephrol. 2017 Dec;28(12):3605-3615. doi: 10.1681/ASN.2016080926. Epub 2017 Aug 7.

24.

Intravenous immunoglobulin therapy in kidney transplant recipients with de novo DSA: Results of an observational study.

Matignon M, Pilon C, Commereuc M, Grondin C, Leibler C, Kofman T, Audard V, Cohen J, Canoui-Poitrine F, Grimbert P.

PLoS One. 2017 Jun 27;12(6):e0178572. doi: 10.1371/journal.pone.0178572. eCollection 2017.

25.

Outcome and Treatment of Nocardiosis After Solid Organ Transplantation: New Insights From a European Study.

Lebeaux D, Freund R, van Delden C, Guillot H, Marbus SD, Matignon M, Van Wijngaerden E, Douvry B, De Greef J, Vuotto F, Tricot L, Fernández-Ruiz M, Dantal J, Hirzel C, Jais JP, Rodriguez-Nava V, Jacobs F, Lortholary O, Coussement J; European Study Group for Nocardia in Solid Organ Transplantation ; European Study Group for Nocardia in Solid Organ Transplantation .

Clin Infect Dis. 2017 May 15;64(10):1396-1405. doi: 10.1093/cid/cix124. Erratum in: Clin Infect Dis. 2017 Oct 15;65(8):1431-1433.

26.

C1q binding is not an independent risk factor for kidney allograft loss after an acute antibody-mediated rejection episode: a retrospective cohort study.

Moktefi A, Parisot J, Desvaux D, Canoui-Poitrine F, Brocheriou I, Peltier J, Audard V, Kofman T, Suberbielle C, Lang P, Rondeau E, Grimbert P, Matignon M.

Transpl Int. 2017 Mar;30(3):277-287. doi: 10.1111/tri.12905.

27.

Monotypic plasma cell interstitial nephritis as the only clinical manifestation in a patient with previously undiagnosed indolent multiple myeloma: A case report.

Attias P, Moktefi A, Matignon M, Dupuis J, Debiais-Delpech C, Grimbert P, Lang P, Audard V.

Medicine (Baltimore). 2016 Aug;95(31):e4391. doi: 10.1097/MD.0000000000004391.

28.

Rituximab for Severe Membranous Nephropathy: A 6-Month Trial with Extended Follow-Up.

Dahan K, Debiec H, Plaisier E, Cachanado M, Rousseau A, Wakselman L, Michel PA, Mihout F, Dussol B, Matignon M, Mousson C, Simon T, Ronco P; GEMRITUX Study Group.

J Am Soc Nephrol. 2017 Jan;28(1):348-358. doi: 10.1681/ASN.2016040449. Epub 2016 Jun 27.

29.

Transcriptomic Signature of the CD24hi CD38hi Transitional B Cells Associated With an Immunoregulatory Phenotype in Renal Transplant Recipients.

Bigot J, Pilon C, Matignon M, Grondin C, Leibler C, Aissat A, Pirenne F, Cohen JL, Grimbert P.

Am J Transplant. 2016 Dec;16(12):3430-3442. doi: 10.1111/ajt.13904. Epub 2016 Jul 14.

30.

Anti-HLA sensitization after kidney allograft nephrectomy: changes one year post-surgery and beneficial effect of intravenous immunoglobulin.

Matignon M, Leibler C, Moranne O, Salomon L, Charron D, Lang P, Jacquelinet C, Suberbielle C, Grimbert P.

Clin Transplant. 2016 Jun;30(6):731-40. doi: 10.1111/ctr.12743. Epub 2016 May 2.

PMID:
27140447
31.

Morbidity and mortality of sickle cell disease patients starting intermittent haemodialysis: a comparative cohort study with non- Sickle dialysis patients.

Nielsen L, Canouï-Poitrine F, Jais JP, Dahmane D, Bartolucci P, Bentaarit B, Gellen-Dautremer J, Remy P, Kofman T, Matignon M, Suberbielle C, Jacquelinet C, Wagner-Ballon O, Sahali D, Lang P, Damy T, Galactéros F, Grimbert P, Habibi A, Audard V.

Br J Haematol. 2016 Jul;174(1):148-52. doi: 10.1111/bjh.14040. Epub 2016 Mar 17.

PMID:
26992059
32.

Successful Treatment of Lung Calciphylaxis With Sodium Thiosulfate in a Patient With Sickle Cell Disease: A Case Report.

Arrestier R, Dudreuilh C, Remy P, Boulahia G, Bentaarit B, Leibler C, Adedjouma A, Kofman T, Matignon M, Sahali D, Dufresne R, Deux JF, Colin C, Grimbert P, Lang P, Bartolucci P, Maitre B, Tran Van Nhieu J, Audard V.

Medicine (Baltimore). 2016 Feb;95(6):e2768. doi: 10.1097/MD.0000000000002768.

33.

Development and validation of a prognostic index for allograft outcome in kidney recipients with transplant glomerulopathy.

Patri P, Seshan SV, Matignon M, Desvaux D, Lee JR, Lee J, Dadhania DM, Serur D, Grimbert P, Hartono C, Muthukumar T.

Kidney Int. 2016 Feb;89(2):450-8.

34.

Th-17 Alloimmune Responses in Renal Allograft Biopsies From Recipients of Kidney Transplants Using Extended Criteria Donors During Acute T Cell-Mediated Rejection.

Matignon M, Aissat A, Canoui-Poitrine F, Grondin C, Pilon C, Desvaux D, Saadoun D, Barathon Q, Garrido M, Audard V, Rémy P, Lang P, Cohen J, Grimbert P.

Am J Transplant. 2015 Oct;15(10):2718-25. doi: 10.1111/ajt.13304. Epub 2015 May 18.

35.

Kidney transplant recipients treated with belatacept exhibit increased naïve and transitional B cells.

Leibler C, Matignon M, Pilon C, Montespan F, Bigot J, Lang P, Carosella ED, Cohen J, Rouas-Freiss N, Grimbert P, Menier C.

Am J Transplant. 2014 May;14(5):1173-82. doi: 10.1111/ajt.12721. Epub 2014 Apr 14.

36.

Urinary cell mRNA profiles and differential diagnosis of acute kidney graft dysfunction.

Matignon M, Ding R, Dadhania DM, Mueller FB, Hartono C, Snopkowski C, Li C, Lee JR, Sjoberg D, Seshan SV, Sharma VK, Yang H, Nour B, Vickers AJ, Suthanthiran M, Muthukumar T.

J Am Soc Nephrol. 2014 Jul;25(7):1586-97. doi: 10.1681/ASN.2013080900. Epub 2014 Mar 7.

37.

APOL1 polymorphisms and development of CKD in an identical twin donor and recipient pair.

Kofman T, Audard V, Narjoz C, Gribouval O, Matignon M, Leibler C, Desvaux D, Lang P, Grimbert P.

Am J Kidney Dis. 2014 May;63(5):816-9. doi: 10.1053/j.ajkd.2013.12.014. Epub 2014 Feb 8.

38.

LMX1B mutations cause hereditary FSGS without extrarenal involvement.

Boyer O, Woerner S, Yang F, Oakeley EJ, Linghu B, Gribouval O, Tête MJ, Duca JS, Klickstein L, Damask AJ, Szustakowski JD, Heibel F, Matignon M, Baudouin V, Chantrel F, Champigneulle J, Martin L, Nitschké P, Gubler MC, Johnson KJ, Chibout SD, Antignac C.

J Am Soc Nephrol. 2013 Jul;24(8):1216-22. doi: 10.1681/ASN.2013020171. Epub 2013 May 16.

39.
40.

Rituximab therapy prevents focal and segmental glomerulosclerosis recurrence after a second renal transplantation.

Audard V, Kamar N, Sahali D, Cardeau-Desangles I, Homs S, Remy P, Aouizerate J, Matignon M, Rostaing L, Lang P, Grimbert P.

Transpl Int. 2012 May;25(5):e62-6. doi: 10.1111/j.1432-2277.2012.01462.x. Epub 2012 Mar 13.

41.

Acute interstitial nephritis with predominant plasmacytic infiltration in patients with HIV-1 infection.

Melica G, Matignon M, Desvaux D, Audard V, Copie-Bergman C, Lang P, Levy Y, Grimbert P.

Am J Kidney Dis. 2012 May;59(5):711-4. doi: 10.1053/j.ajkd.2011.12.017. Epub 2012 Feb 18.

PMID:
22342319
42.

Ciliopathies with skeletal anomalies and renal insufficiency due to mutations in the IFT-A gene WDR19.

Bredrup C, Saunier S, Oud MM, Fiskerstrand T, Hoischen A, Brackman D, Leh SM, Midtbø M, Filhol E, Bole-Feysot C, Nitschké P, Gilissen C, Haugen OH, Sanders JS, Stolte-Dijkstra I, Mans DA, Steenbergen EJ, Hamel BC, Matignon M, Pfundt R, Jeanpierre C, Boman H, Rødahl E, Veltman JA, Knappskog PM, Knoers NV, Roepman R, Arts HH.

Am J Hum Genet. 2011 Nov 11;89(5):634-43. doi: 10.1016/j.ajhg.2011.10.001. Epub 2011 Oct 20.

43.

Intrarenal IFN-γ mRNA expression differentiates clinical and subclinical glomerulitis in renal transplant recipients.

Buob D, Hazan M, Homs S, Matignon M, Mansour H, Audard V, Desvaux D, Remy P, Noel C, Bastuji-Garin S, Cohen J, Lang P, Grimbert P.

Transplantation. 2011 Jul 27;92(2):170-5. doi: 10.1097/TP.0b013e31821eab65.

PMID:
21546865
44.

[Organ transplantation and blood transfusion].

Matignon M, Bonnefoy F, Lang P, Grimbert P.

Transfus Clin Biol. 2011 Apr;18(2):70-8. doi: 10.1016/j.tracli.2011.02.005. Epub 2011 Mar 12. Review. French.

PMID:
21398160
45.

Rituximab treatment for membranous nephropathy: a French clinical and serological retrospective study of 28 patients.

Michel PA, Dahan K, Ancel PY, Plaisier E, Mojaat R, De Seigneux S, Daugas E, Matignon M, Mesnard L, Karras A, François H, Pardon A, Caudwell V, Debiec H, Ronco P.

Nephron Extra. 2011 Jan;1(1):251-61. doi: 10.1159/000333068. Epub 2011 Dec 24.

46.

Renal transplantation in HIV-infected patients: the Paris experience.

Touzot M, Pillebout E, Matignon M, Tricot L, Viard JP, Rondeau E, Legendre C, Glotz D, Delahousse M, Lang P, Peraldi MN.

Am J Transplant. 2010 Oct;10(10):2263-9. doi: 10.1111/j.1600-6143.2010.03258.x. Epub 2010 Sep 14.

47.

Renal transplantation in patients with sarcoidosis: a French multicenter study.

Aouizerate J, Matignon M, Kamar N, Thervet E, Randoux C, Moulin B, Raffray L, Buchler M, Villar E, Mahevas M, Desvaux D, Dahan K, Diet C, Audard V, Lang P, Grimbert P.

Clin J Am Soc Nephrol. 2010 Nov;5(11):2101-8. doi: 10.2215/CJN.03970510. Epub 2010 Jul 29.

48.

T-cell phenotype in protocol renal biopsy from transplant recipients treated with belatacept-mediated co-stimulatory blockade.

Grimbert P, Audard V, Diet C, Matignon M, Plonquet A, Mansour H, Desvaux D, Durrbach A, Cohen JL, Lang P.

Nephrol Dial Transplant. 2011 Mar;26(3):1087-93. doi: 10.1093/ndt/gfq453. Epub 2010 Jul 28.

PMID:
20667993
49.

c-mip impairs podocyte proximal signaling and induces heavy proteinuria.

Zhang SY, Kamal M, Dahan K, Pawlak A, Ory V, Desvaux D, Audard V, Candelier M, BenMohamed F, Matignon M, Christov C, Decrouy X, Bernard V, Mangiapan G, Lang P, Guellaën G, Ronco P, Sahali D.

Sci Signal. 2010 May 18;3(122):ra39. doi: 10.1126/scisignal.2000678. Erratum in: Sci Signal. 2010;3(123):er7. Mohamed, Fatima Ben [corrected to BenMohamed, Fatima].

50.

Yeast contamination of kidney, liver and cardiac preservation solutions before graft: need for standardisation of microbial evaluation.

Botterel F, Foulet F, Legrand P, Soria AM, Farrugia C, Grimbert P, Matignon M, Lauzet JY, Guerrini P, Bretagne S.

J Hosp Infect. 2010 Sep;76(1):52-5. doi: 10.1016/j.jhin.2010.02.008. Epub 2010 May 1.

PMID:
20435373

Supplemental Content

Loading ...
Support Center